The release by the National Health Surveillance Agency (Anvisa) of the Pfizer vaccine against covid in younger children marks the last weeks of a year of high expectations for immunization to advance. With the obstacles imposed by the federal government, similarly to what happened with the vaccine for adults before, the promise is of new […]